Publications by authors named "Christopher Cammarata"

Claim this Profile
T
TRIAD IX: Can a Patient Testimonial Safely Help Ensure Prehospital Appropriate Critical Versus End-of-Life Care?
Ferdinando Mirarchi, Christopher Cammarata, Timothy E Cooney, Kristin Juhasz, Stanley A Terman

J Patient Saf· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intracellular trafficking and cytotoxicity of a gelatine-doxorubicin conjugate in two breast cancer cell lines.
Mohammed M Alvi, Rachel E Nicoletto, Bayan A Eshmawi, Hyun Kate Kim, Christopher R Cammarata

J Drug Target· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Carbodiimide induced cross-linking, ligand addition, and degradation in gelatin.
Christopher R Cammarata, Mitchell E Hughes, Clyde M Ofner

Mol Pharm· March 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
TRIAD VII: do prehospital providers understand Physician Orders for Life-Sustaining Treatment documents?
Ferdinando L Mirarchi, Christopher Cammarata, Samuel W Zerkle, Timothy E Cooney, Jason Chenault

J Patient Saf· March 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
RE: The Oregon Physician Orders for Life-Sustaining Treatment Registry.
Ferdinando Mirarchi, Christopher Cammarata

J Emerg Med· February 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preparation, drug release, and cell growth inhibition of a gelatin: doxorubicin conjugate.
Darren C Wu, Christopher R Cammarata, Hyun Joo Park, Brian T Rhodes, Clyde M Ofner

Pharm Res· August 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis